Hormone Replacement Therapy: A Complete Guide for Midlife

What HRT is — and what it is not

Hormone replacement therapy is the medical use of estrogen, progesterone, or testosterone (alone or in combination) to restore hormone levels that have declined with age or medical illness. In women, HRT is most commonly used to relieve the symptoms of perimenopause and menopause and to protect long-term bone, cardiovascular, and cognitive health. In men, testosterone replacement therapy (TRT) is used when clinical symptoms of low testosterone are paired with confirmed low serum levels.

HRT is not a single drug and not a single dose. Modern prescribing uses the lowest effective dose of the most physiologic form (typically bioidentical 17β-estradiol and micronized progesterone), delivered by the route that best fits the person's risk profile and preferences — a transdermal patch, gel, cream, oral capsule, vaginal insert, pellet, or injection.

Who may benefit

HRT is worth a conversation for adults who are experiencing symptoms consistent with hormone decline and who do not have absolute contraindications. Common patterns include:

• Hot flashes, night sweats, and disrupted sleep in the years around the final menstrual period.
• Vaginal dryness, urinary urgency, or recurrent UTIs (the genitourinary syndrome of menopause).
• New or worsening anxiety, low mood, brain fog, and word-finding difficulty in midlife.
• Loss of muscle, stubborn central weight gain, and declining exercise tolerance despite consistent effort.
• Early bone density loss, family history of osteoporosis, or a personal history of early menopause.
• Men with fatigue, low libido, erectile changes, mood decline, and confirmed low morning testosterone on two separate measurements.

Estrogen, progesterone, and testosterone — a plain-language primer

Estradiol is the primary estrogen of the reproductive years. It supports vasomotor stability (fewer hot flashes), sleep architecture, mood, cognition, bone remodeling, joint lubrication, vaginal and bladder tissue, skin collagen, and cardiovascular tone. Transdermal estradiol (patch, gel, or cream) avoids the first-pass liver effect associated with oral formulations and is generally the preferred route in people with elevated cardiovascular or clotting risk.

Progesterone balances estrogen in anyone with a uterus by preventing overgrowth of the endometrial lining. Beyond that role, oral micronized progesterone taken at bedtime is often calming and sleep-promoting, and is the form best supported by long-term safety data. Synthetic progestins (such as medroxyprogesterone acetate) are a different molecule with a different risk profile and are not the same thing as bioidentical progesterone.

Testosterone is not just a "male" hormone. Women make testosterone in the ovaries and adrenal glands, and low levels can contribute to fatigue, low libido, loss of motivation, and muscle decline. In men, testosterone replacement is prescribed only when symptoms and lab values agree, and is monitored with periodic hematocrit, PSA, and estradiol measurements.

What the evidence actually says about risk

Much of the fear surrounding HRT traces back to the 2002 Women's Health Initiative (WHI), which studied oral conjugated equine estrogen with or without medroxyprogesterone in women whose average age was 63 — more than a decade past menopause. The initial reports were widely interpreted as showing that "hormones cause cancer and heart disease," and prescribing collapsed almost overnight.

Two decades of re-analysis have substantially changed that picture. The current consensus of the North American Menopause Society, the Endocrine Society, and the International Menopause Society is that, for healthy women who begin HRT within roughly ten years of their final period or before age 60, the benefits generally outweigh the risks. Transdermal estradiol has not been shown to raise the risk of venous thromboembolism or stroke in observational data. Micronized progesterone has a more favorable breast profile than the synthetic progestin used in the WHI. Absolute risks — when they exist — remain small and must be weighed against the well-documented benefits for symptoms, bone density, and quality of life.

HRT is not appropriate for everyone. Personal history of breast cancer, active liver disease, unexplained vaginal bleeding, recent stroke or heart attack, and active clotting disorders are all reasons to pause and individualize. Family history alone is not an automatic disqualifier and deserves a real conversation.

A functional-medicine approach

Hormones do not operate in isolation. Sleep debt, chronic stress, blood-sugar instability, gut dysfunction, thyroid disease, iron deficiency, and nutrient gaps all shape how a person experiences their own hormone levels. A serum estradiol number tells us very little without the context of the person carrying it.

At Sovera Health, a hormone evaluation typically begins with a detailed history of menstrual pattern, symptom timeline, sleep, mood, cognition, sexual health, and prior treatment. From there, we consider targeted labs — which may include estradiol, progesterone, total and free testosterone, SHBG, DHEA-S, thyroid panel, fasting insulin and glucose, lipid subfractions, ferritin, vitamin D, and inflammatory markers — chosen based on the individual, not a template.

When HRT is a good fit, we generally start with transdermal estradiol paired with oral micronized progesterone (for anyone with a uterus), adjust the dose to symptoms and tolerability rather than to a single number, and reassess at six to twelve weeks. Testosterone, DHEA, and vaginal estrogen are added when they address a specific problem. Nothing is prescribed without an informed consent conversation about what to expect and what to watch for.

What to expect in the first year

Most people notice a change in vasomotor symptoms and sleep within two to four weeks. Mood and cognitive benefits often follow over the next one to three months. Bone, cardiovascular, and body-composition benefits accumulate over longer stretches of consistent use. Dose refinement is normal — most people settle into a stable regimen after two to three adjustments.

Follow-up visits check symptoms first, labs second. We reassess breast health, blood pressure, and — when relevant — hematocrit, lipid panel, and estradiol level. Screening mammography, bone density, and cardiovascular prevention continue on their usual schedules.

Common questions

Do I have to be in menopause to start?

No. Perimenopause — the transition — is often when symptoms are the most disruptive, and low-dose HRT can be appropriate well before the final menstrual period.

Are pellets the "gold standard"?

Pellets deliver supraphysiologic doses that cannot be adjusted once inserted and have been associated with higher rates of side effects. They are not the standard of care in mainstream menopause medicine.

How long can I stay on HRT?

There is no arbitrary stop date. As long as the benefits continue to outweigh the risks for you as an individual, continued use is reasonable and is a decision to revisit annually.

Will HRT make me gain weight?

No. HRT tends to preserve lean mass and reduce the shift toward central adiposity that accompanies estrogen decline. Weight change during midlife is more strongly driven by sleep, insulin resistance, and sarcopenia.

Working with Sovera Health

Sovera Health provides functional-medicine telehealth to adults located in Texas. New patients begin with a comprehensive intake visit focused on the whole picture — sleep, stress, metabolism, gut, thyroid, and hormones — and leave with a clear plan for testing and next steps. Care is cash-pay; eligible serum labs may be billed through insurance.